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Background/objectives: Although the current evidence is insufficient to recommend a 
special diet for people with multiple sclerosis (MS), dietary advice for people with MS is 
prolific online and in the media. This study aimed to describe dietary changes made in 
the year following a first clinical diagnosis of central nervous system demyelination (FCD), 
a common precursor to MS.
subjects/methods: We used follow-up data from the Ausimmune Study, a multicentre 
matched case-control study examining the environmental risk factors for a FCD. 
A total of 244 cases (60 male, 184 female) completed a 1-year follow-up interview, which 
included a question about dietary changes. We described the number and proportion 
(%) of participants who reported making dietary changes and the type of change made. 
We investigated independent predictors of making a dietary change using a multivariable 
logistic regression model.
results: A total of 38% (n = 92) of participants at the 1-year follow-up reported making 
at least one dietary change over the last year. There were no statistically significant 
independent associations between any participant characteristic and odds of making 
a dietary change. Of those who made at least one dietary change, the most common 
changes were increasing fruit and/or vegetable intake (27%, n = 25) and following a 
low-fat diet (25%, n = 23).
conclusion: A considerable proportion of the study population reported making at least 
one dietary change in the year following a FCD, with the majority of changes being 
toward a healthier diet. Further research is warranted to investigate the reasons behind 
any dietary changes adopted by people with a FCD or with MS, and whether making 
a dietary change has benefits for the progression of demyelinating diseases, e.g., to a 
diagnosis of MS, as well as for general health and well-being.
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inTrODUcTiOn
Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system (CNS), char-
acterized by inflammatory damage of the myelin sheaths that insulate and protect the CNS axons (1). 
With the exclusion of traumatic brain injury, MS is the most common cause of neurological disability 
in young adults (2). It is estimated to affect more than 2 million people globally—approximately three 
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quarters of whom are women—and it is currently incurable (3). 
Although the specific etiology of MS is unknown, both genetic 
and environmental factors, including higher latitude, low vitamin 
D status, smoking, and history of infectious mononucleosis, are 
associated with increased risk of f MS (4).
A number of restrictive diets are promoted online and in 
the media for people with MS, including the Swank Diet (5) 
(saturated fat restricted to <20 g/day; unsaturated fat restricted to 
20–40 g/day); the Overcoming MS (OMS) Recovery Program (6) 
(low in saturated fat; moderate in seafood, avocado and nuts; no 
meat, dairy, egg yolks, or refined foods); and the Paleo diet (high 
in meat, vegetables, and fruits; no dairy, legumes, or grains) (7). 
There is little empirical evidence to support the benefits of such 
dietary modifications for disease activity or progression in MS. 
However, following a healthy diet (e.g., increasing consumption 
of vegetables, fruits, whole grains, legumes, nuts and seeds, and 
oily fish; and limiting red meat, animal products, and highly pro-
cessed foods) may improve overall well-being in people with MS 
(8, 9) and reduce the symptoms and co-morbidities associated 
with MS, such as fatigue and obesity (10).
Using data from the 2003–2006 Australian Multicentre Study 
of Environment and Immune Function (Ausimmune) Study, we 
investigated the types of dietary changes made by participants 
after a first clinical diagnosis of CNS demyelination (FCD), a 
common precursor to MS. We investigated whether demographic 
factors or lifestyle characteristics influenced whether a participant 
made a dietary change or not.
MaTerials anD MeThODs
study Design and Population
The Ausimmune Study was a multicentre case–control study in 
four regions of Australia along the south-eastern and eastern 
seaboard, namely Brisbane city, Newcastle region, Geelong and 
the Western Districts of Victoria, and Tasmania (11). The study 
aimed to explore the environmental risk factors for developing a 
FCD. Further details of the Ausimmune Study have been docu-
mented elsewhere (11).
In brief, cases were aged between 18 and 59 years, and diag-
nosed with a FCD during the study period of November 2003 
to December 2006. Study neurologists reviewed all clinical data 
(including magnetic resonance imaging scans) to confirm the 
diagnosis and eligibility to participate.
At baseline there were 282 case participants who had a FCD 
within the study period. This included 216 participants with a 
classic first demyelinating event within the study period, 18 
participants presenting for the first time with primary progres-
sive MS, and 48 participants who had received a first diagnosis 
of CNS demyelination, but provided a history consistent with a 
prior neurological event consistent with demyelination, and were 
thus now diagnosed as having MS.
At 1-year from initial entry into the Ausimmune Study, case 
participants were invited to complete a telephone interview 
with a research nurse. A total of 244 cases completed the 1-year 
telephone review, providing data for this analysis. Of those, 186 
had had a classic FDE at baseline, 44 had had a prior neurological 
event, and 14 had been diagnosed with primary progressive MS. 
Written informed consent was obtained from all participants 
and they were free to withdraw from the study at any time. Nine 
regional Human Research Ethics Committees approved the 
Ausimmune Study.
Data collection
Baseline Data
Participants completed questionnaires prior to, and during, a 
face-to-face interview with a research nurse. Data were collected 
on participant characteristics, including age, sex, ethnicity, 
education, usual physical activity in the last 12  months when 
the person was not ill [using the International Physical Activity 
Questionnaire (IPAQ)] (12) and known risk factors for MS, 
such as smoking and history of infectious mononucleosis. At the 
interview, a study nurse measured height and weight, and a blood 
sample was taken by venepuncture.
1-Year Follow-Up
At the 1-year review, participants were asked: “Have you changed 
your diet over the last year? If yes, how?” This was an open field 
question where the responses were coded by the interviewer into 
seven categories as per the coding guide: more fish/high fish, 
more vitamin D, low-fat diet, low-dairy diet, high-fiber diet, 
special MS diet (e.g., Swank diet), and other. The “other” category 
was a free text field. Participants could describe more than one 
dietary change.
statistical analysis
Ethnicity was categorized as Caucasian or other. Physical activity 
was categorized as low, medium, or high physical activity, accord-
ing to the IPAQ scoring protocol (12). Body mass index (BMI) 
was calculated as weight in kilograms divided by height in metres 
squared and categorized as underweight, normal, overweight, and 
obese, using the standard cut-points according to ethnicity (13). 
Only two participants were categorized as underweight; hence, 
underweight participants were combined with the normal weight 
group for analysis purposes. Dietary changes that were reported 
by at least five participants (including those captured in the free 
text field) were used to create ten final dietary change categories: 
(1) increased fruit and/or vegetables; (2) low-fat diet; (3) reduced 
discretionary foods, including alcohol; (4) increased fish; (5) 
reduced meat; (6) reduced or eliminated gluten/wheat; (7) high 
fiber diet; (8) low dairy diet; (9) increased water/fluids; and (10) 
reduced saturated fat intake. Dietary changes that were reported 
by fewer than five participants were grouped into “other.”
Using the number and proportion (%), we described the 
characteristics (sex, age at follow up, ethnicity, study region, 
education at baseline, physical activity at baseline, BMI category 
at baseline, smoking at baseline) of those who did and did not 
make a dietary change. Missing data for characteristics were 
as follows: ethnicity, n =  2; education, n =  2; physical activity, 
n = 19; BMI category, n = 1; and smoking, n = 3. We described 
the number and proportion (%) of participants making specific 
types of dietary changes. We used univariate logistic regression 
models to investigate potential predictors of making a dietary 
change. In addition, we used a multivariable logistic regression 
TaBle 1 | Characteristics of participants (n = 244) in the 1-year follow-up of the 
Ausimmune Study according to whether or not they made at least one dietary 
change in the year after a first clinical diagnosis of CNS demyelination.
Made at least 
one dietary 
change (n = 92)
Made no dietary 
changes  
(n = 152)
sex, % (n)
Male 22.8 (21) 25.7 (39)
Female 77.2 (71) 74.3 (113)
age group at follow-up, % (n)
20–29 years 17.4 (16) 19.1 (29)
30–39 years 39.1 (36) 29.0 (44)
40–49 years 30.4 (28) 34.9 (53)
50–59 years 13.0 (12) 17.1 (26)
ethnicity, % (n)
Caucasian 97.8 (89) 96.0 (145)
Other 2.2 (2) 4.0 (6)
study region, % (n)
Brisbane (27°S) 29.4 (27) 25.7 (39)
Newcastle (33°S) 17.4 (16) 12.5 (19)
Geelong (37°S) 28.3 (26) 25.0 (38)
Tasmania (43°S) 25.0 (23) 36.8 (56)
education at baseline, % (n)
Year 10 or less 21.7 (20) 28.7 (43)
Year 12 and TAFE 54.4 (50) 47.3 (71)
University 23.9 (22) 24.0 (36)
Physical activity at baseline, % (n)
Low 18.8 (16) 17.1 (24)
Moderate 38.8 (33) 34.3 (48)
High 42.4 (36) 48.6 (68)
BMi category at baseline, % (n)
Normal/underweight (≤24.9) 45.7 (42) 43.7 (66)
Overweight (25–29.9) 20.7 (19) 33.8 (51)
Obese class 1 (30–34.9) 18.5 (17) 15.2 (23)
Obese class 2 (≥35) 15.2 (14) 7.3 (11)
smoking at baseline, % (n)
Current smoker 27.5 (25) 30.0 (45)
Past smoker 38.5 (35) 30.0 (45)
Never smoked 34.1 (31) 40.0 (60)
TAFE, Technical and Further Education.
Missing data as follows: ethnicity, n = 2; education, n = 2; physical activity, n = 19; 
Body mass index (BMI) category, n = 1; and smoking, n = 3.
TaBle 2 | Univariate logistic regression modelsa showing associations between 
each participant characteristic and odds of making a dietary change.
n Or (95% ci) P
Sex (female vs. male) 244 1.17 (0.64, 2.14) 0.619
Age group at follow-up, years 244
20–29 Reference
30–39 1.48 (0.70, 3.15) 0.305
40–49 0.96 (0.45, 2.05) 0.911
50–59 0.84 (0.33, 2.09) 0.703
Ethnicity (other vs. Caucasian) 242 0.54 (0.11, 2.75) 0.461
Study region 244
Brisbane (27°S) Reference
Newcastle (33°S) 1.22 (0.53, 2.78) 0.642
Geelong (37°S) 0.99 (0.49, 1.99) 0.974
Tasmania (43°S) 0.59 (0.30, 1.18) 0.138
Education at baseline 242
Year 10 or less Reference
Year 12 and TAFE 1.51 (0.80, 2.88) 0.205
University 1.31 (0.62, 2.78) 0.476
Physical activity at baseline 225
Low Reference
Moderate 1.03 (0.48, 2.23) 0.938
High 0.79 (0.37, 1.68) 0.547
Body mass index category at baseline 243
Normal/underweight (≤24.9) Reference
Overweight (25–29.9) 0.59 (0.30, 1.13) 0.108
Obese class 1 (30–34.9) 1.16 (0.56, 2.43) 0.690
Obese class 2 (≥35) 2.00 (0.83, 4.82) 0.122
Smoking at baseline 241
Current smoker Reference
Past smoker 1.51 (0.81, 2.80) 0.195
Never smoked 1.08 (0.56, 2.07) 0.828
TAFE, Technical And Further Education.
aA separate model was run for each characteristic.
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model (n = 221) to investigate potential independent predictors 
of making a dietary change, with all variables included in a single 
model. Data were analyzed using SPSS statistical software for 
Windows (Version 23.0, IBM Corp., Armonk, NY, USA) and 
Stata Statistical Software (Release 14, College Station, TX, USA: 
StataCorp LP). Statistical significance was defined as P < 0.05.
resUlTs
The characteristics of the 244 participants with 1-year follow-
up data are shown in Table  1. Over one-third of participants 
(n =  92, 38%), reported making at least one dietary change in 
the year following a FCD. There were no statistically significant 
associations between any participant characteristic and the odds 
of making a dietary change in the univariate logistic regression 
models (Table  2), nor in the multivariable logistic regression 
model (Table 3). Obesity at baseline was associated with a 60% 
increase in the odds of making a dietary change compared to 
being normal weight/underweight, although the association did 
not reach statistical significance (Table 3).
Table 4 shows the types of dietary changes made by participants. 
The most common dietary changes were increasing fruit and/or 
vegetable intake (n = 25) and following a low-fat diet (n = 23). 
The descriptions of dietary changes adopted by fewer than five 
participants are detailed in Table S1 in Supplementary Material. 
Many of the changes were reported by only one participant, and 
not all changes were healthy (e.g., increased consumption of 
discretionary foods).
DiscUssiOn
A considerable proportion of the study population (38%) reported 
making at least one dietary change in the year following a FCD. 
The majority of changes were toward a healthier diet, including a 
move toward higher vegetable and fruit consumption, following 
a low-fat diet, and reduced consumption of discretionary foods. 
This is in contrast to a study of dietary change in the general 
Australian population, where there was a change in diet over 
15 years to a higher energy density diet, particularly among older 
people (14).
TaBle 4 | Types of dietary changes reported by those participants who made at 
least one dietary change (n = 92).
Males  
(n = 21)
Females 
(n = 71)
% n % n
Increased fruit and/or vegetables 23.8 5 28.2 20
Low-fat diet 28.6 6 23.9 17
Reduced discretionary foods 33.3 7 16.9 12
Increased fish 9.5 2 16.3 15
Reduced meat 23.8 5 16.9 12
Reduced gluten 19.0 4 12.7 9
High-fiber diet 19.0 4 9.9 7
Low-dairy diet 0 0 11.3 8
Increased fluids 23.8 5 4.2 3
Reduced saturated fat 4.8 1 7.0 5
Othera 71.4 15 84.5 60
Participants could select more than one type of dietary change.
aSee Table S1 in Supplementary Material for a list of other dietary changes made by 
fewer than five participants.
TaBle 3 | A multivariable logistic regression modela showing independent 
associations between participant characteristics and odds of making a dietary 
change (n = 221).
Or (95% ci) P
Sex (female vs. male) 1.23 (0.60, 2.52) 0.575
age at follow-up, years
20–29 Reference
30–39 1.43 (0.61, 3.36) 0.417
40–49 0.81 (0.35, 1.89) 0.630
50–59 0.61 (0.21, 1.75) 0.356
Ethnicity (other vs. Caucasian) 1.03 (0.17, 6.12) 0.971
study region
Brisbane (27°S) Reference
Newcastle (33°S) 1.84 (0.71, 4.77) 0.210
Geelong (37°S) 1.16 (0.52, 2.61) 0.711
Tasmania (43°S) 0.92 (0.42, 2.00) 0.824
education at baseline
Year 10 or less Reference
Year 12 and TAFE 1.63 (0.75, 3.55) 0.215
University 1.37 (0.56, 3.33) 0.493
Physical activity at baseline
Low Reference
Moderate 1.04 (0.45, 2.41) 0.924
High 0.93 (0.41, 2.15) 0.870
Body mass index category at baseline
Normal/underweight (≤24.9) Reference
Overweight (25–29.9) 0.56 (0.26, 1.18) 0.128
Obese class 1 (30–34.9) 1.61 (0.69, 3.73) 0.270
Obese class 2 (≥35) 1.62 (0.56, 4.70) 0.378
smoking at baseline
Current smoker Reference
Past smoker 1.78 (0.86, 3.68) 0.118
Never smoked 1.28 (0.60, 2.76) 0.522
TAFE, Technical and Further Education.
aAll characteristics included in a single model.
4
Russell et al. Dietary Changes and MS
Frontiers in Neurology | www.frontiersin.org March 2018 | Volume 9 | Article 161
dietary changes that people are making after a FCD. It is likely that 
there is confusion about what changes are beneficial for people 
with MS and those at high risk of MS, with no consistent advice 
being provided by clinicians and other health-care professionals. 
Improvements in the strength of evidence about suitable dietary 
changes for people with MS or those at high risk of MS, coupled 
with improved nutrition education, would perhaps result in more 
consistent dietary changes. Not all changes were toward a healthier 
diet, with a few participants reporting increased convenience and 
discretionary food consumption. Greater prevalence of anxiety, 
depression and fatigue is well-described in people with CNS 
demyelination and MS (15, 16), and may account for this increase 
in unhealthy food choices.
To our knowledge, no other studies have investigated dietary 
changes in people with a FCD; however, some studies have 
reported dietary changes made by people with MS. In Germany, 
Schwarz and colleagues reported complementary and alternative 
medicine (CAM) use, including “diet modification,” in mem-
bers from the AMSEL (Aktion Multiple Sklerose Erkrankter 
Landesverband) Baden-Wuerttemberg regional chapter of the 
German MS Society, based on postal surveys (n = 1,573, aver-
age disease duration of 14 years) (17). Dietary modification was 
the most popular type of CAM, with 31% currently following a 
modified diet (17). Also in Germany, Riemann-Lorenz and col-
leagues conducted a web-based survey of 337 people with MS 
who visited the German MS Society website, and found that 42% 
of participants had previously—or were currently—following a 
diet since their MS diagnosis (18). Of those who reported dietary 
changes, 25% modified their fat intake, 21% eliminated meat, 
22% followed a vegetarian pattern, and 17% reduced meat and 
increased fish intake (18). Approximately a quarter of participants 
reported ending their diet, with reasons such as the diet was too 
restrictive, too expensive, too much effort, or they felt no effect 
(18). A smaller study in the United States reported that 17% of 
participants with MS were currently attempting a diet, and the 
majority (91%) were willing to attempt dietary modification as 
a means of benefiting their disease (19). Participants were most 
willing to follow the Paleo diet or a high-carbohydrate diet (19).
There has only been one Australian study investigating the 
dietary changes made after a diagnosis of MS. A postal survey 
was conducted by Leong and colleagues to examine dietary 
interventions used by people with MS who were recipients of 
the South Australian MS Society Newsletter (n = 416) (20). The 
number of dietary interventions reported by participants ranged 
from none to 11, with the median reported as one. A total of 40% 
of participants reported following a low-fat diet, 24% reduced or 
eliminated sugar, 16% excluded wheat or gluten, and 11% fol-
lowed the Swank diet. It is not clear if the dietary modifications 
reported were concerning current use, or inclusive of lifetime use 
prior to a diagnosis of MS.
In our study, very few participants reported following a special 
diet for MS (e.g., the Swank Diet, the OMS Recovery Program 
and the Paleo diet). These diets may be more commonly adopted 
by people with diagnosed MS (rather than with a FCD). For 
example, a study in the United States (n =  3,140) showed that 
16% of people with MS followed the Swank Diet for an average of 
4 years, with the intention to treat overall MS symptoms, fatigue, 
Many types of dietary changes in this study were adopted by 
fewer than five participants, and most of these were adopted by 
only one or two people. This indicates a lack of consistency in the 
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and loss of appetite (21). The baseline and initial follow-up phases 
of the Ausimmune Study were completed more than 10 years ago. 
It is possible that diets such as the OMS Recovery Program and 
the Paleo diet were less widely publicized at that time, and this 
may explain the low uptake of these diets. However, the Swank 
diet has been well-known for many years, yet only one participant 
reported changing to this diet. Our understanding of diet and MS 
has progressed little over the past decade; it thus seems likely that 
the findings of this study remain valid today.
Restrictive diets, particularly those which eliminate entire 
food groups or those that contain strict limitations on dietary 
components such as red meat or saturated fats, have the potential 
to result in vitamin and mineral deficiencies (22, 23). With restric-
tive diets, health consequences—including exacerbation of fatigue 
(24)—may arise if there is no appropriate dietary compensation 
(25). MS Australia does not support a special dietary protocol 
for MS; rather, it recommends a diet that is high in vegetables, 
fruits, legumes, and whole grains; moderate in dairy intake; low 
in saturated fat; and includes oily fish for long chain omega-3 fatty 
acids (26). This is in line with the Australian Dietary Guidelines 
(27). Higher consumption of fruits and vegetables may reduce 
the risk of coronary heart disease and stroke, and may protect 
against weight gain and some cancers (27). Weight gain is com-
mon in people with MS (24) and adopting a healthier diet, such as 
increasing fruit and vegetable consumption, may help to prevent 
caloric excess and associated weight gain, which may exacerbate 
symptoms of MS (28).
Given that fewer than 4% of 19- to 50-year olds in Australia 
adhere to the Australian Dietary Guidelines (29), improved nutri-
tion education and dietary counseling to help people with MS 
follow these guidelines may help to enhance their well-being and 
sense of control, particularly in the early stages of the disease. 
A needs analysis was conducted in Australian in 2012 and showed 
that dietetic counseling was a high priority for people with MS; 
however, many felt that their access to such services was not sat-
isfactory (30). The need for improved access to dietary resources 
was highlighted—in particular, dietetic services with a focus on 
MS (30).
A strength of the Ausimmune Study was the multicentre design, 
which enabled data to be captured along a relatively wide latitu-
dinal span in four regions along the Australian eastern seaboard. 
Participant recruitment was after a FCD and thus early in the 
disease course of CNS demyelination, which meant that early 
dietary changes were captured.
There are several limitations to this study. The categories of 
dietary change were coded by the interviewing nurse, which 
may have introduced error through misclassification, especially 
considering the complexity of the diets being described by 
participants. Furthermore, self-reported dietary intake carries 
the inherent risk of social desirability bias, where participants 
generally overestimate healthy behaviors, and portray a more 
desirable diet than they actually consume (31). The relatively 
small sample size may have affected the statistical power of our 
analyses, reducing our capacity to detect any true predictors of 
making a dietary change.
In this Australian population, over one-third of participants 
reported a dietary change in the year following a FCD, largely 
toward a healthier diet. Demographic or lifestyle factors did not 
have a statistically significant influence on the reported dietary 
changes. In order to develop appropriate dietary resources and 
create targeted nutrition education, it is important to understand 
why some people with a FCD or with MS change their diet and 
why others do not, why people choose specific diets, and where 
they obtain their nutrition information. Future research is war-
ranted to investigate the reasons behind any dietary changes 
adopted by people with a FCD or MS, and the barriers faced in 
achieving a healthy diet.
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